Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Diabetic Foot Osteomyelitis: early-phase trial registry

1 of 2 indexed Diabetic Foot Osteomyelitis trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Diabetic Foot Osteomyelitis: 2 US clinical trials tracked, 1 recruiting.

Diabetic Foot Osteomyelitis is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Biocomposites, running 1 of these trials.

Enrollment posture brief

Registry condition diabetic-foot-osteomyelitis

OPEN 1 | RECR 50% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Diabetic Foot Osteomyeli (th…50%
Open-enrollment share among volume-matched conditions near Diabetic Foot Osteomyelitis

Diabetic Foot Osteomyelitis lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Diabetic Foot Osteomyelitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Diabetic Foot Osteomyelitis is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Biocomposites 1 trials
Bonesupport AB 1 trials

Named interventions

Most-linked intervention names on Diabetic Foot Osteomyelitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Systemic Antibiotics Drug
1 trials
Stimulan VG Drug
1 trials
Cerament G Device
1 trials

US sites by state

Facility locations filed on Diabetic Foot Osteomyelitis trials. A trial with sites in several states counts in each.

North Carolina 2 trials
Ohio 1 trials
New York 1 trials
Nevada 1 trials
New Jersey 1 trials
California 1 trials
Arizona 1 trials
Arkansas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Diabetic Foot Osteomyelitis page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Diabetic Foot Osteomyelitis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Biocomposites sponsors the most Diabetic Foot Osteomyelitis trials on record, review their full trial history before evaluating a specific study. See Biocomposites's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diabetic Foot Osteomyelitis condition card totals 2 registered trials; most-linked intervention Systemic Antibiotics; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.